用于检测和鉴定土拉弗朗西斯菌的单克隆抗体的制备。
Preparation of monoclonal antibodies for detection and identification of Francisella tularensis.
作者信息
Hotta Akitoyo, Uda Akihiko, Fujita Osamu, Tanabayashi Kiyoshi, Yamada Akio
机构信息
Department of Veterinary Science, National Institute of Infectious Diseases, Toyama 1-23-1, Tokyo 162-8640, Japan.
出版信息
Clin Vaccine Immunol. 2007 Jan;14(1):81-4. doi: 10.1128/CVI.00057-06. Epub 2006 Nov 22.
Abstract
Monoclonal antibodies (MAbs) against Francisella tularensis were obtained. Three MAbs specifically reacted with F. tularensis, while four MAbs reacted with other members of the genus Francisella as well. Fluorescent isothiocyanate-conjugated MAbs unequivocally stained bacterial cells in specimens from experimentally infected mice. Two MAbs agglutinated F. tularensis antigen in the agglutination tests. These MAbs should improve methods for detection and identification of F. tularensis.
摘要
获得了针对土拉弗朗西斯菌的单克隆抗体（MAbs）。三种单克隆抗体与土拉弗朗西斯菌特异性反应，而另外四种单克隆抗体也与弗朗西斯菌属的其他成员反应。异硫氰酸荧光素偶联的单克隆抗体明确地对实验感染小鼠标本中的细菌细胞进行了染色。两种单克隆抗体在凝集试验中凝集了土拉弗朗西斯菌抗原。这些单克隆抗体应能改进土拉弗朗西斯菌的检测和鉴定方法。
相似文献
1
Preparation of monoclonal antibodies for detection and identification of Francisella tularensis.
Clin Vaccine Immunol. 2007 Jan;14(1):81-4. doi: 10.1128/CVI.00057-06. Epub 2006 Nov 22.
2
Production and partial characterization of hybridoma clones secreting monoclonal antibodies against Francisella tularensis.
Hybridoma. 1993 Apr;12(2):197-202. doi: 10.1089/hyb.1993.12.197.
3
Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
Immunol Lett. 2007 Oct 15;112(2):92-103. doi: 10.1016/j.imlet.2007.07.006. Epub 2007 Aug 8.
4
[The preventive activity of monoclonal antibodies specific to the lipopolysaccharide of Francisella tularensis].
Zh Mikrobiol Epidemiol Immunobiol. 1992(9-10):67-70.
5
Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis.
J Leukoc Biol. 1993 Jan;53(1):112-6. doi: 10.1002/jlb.53.1.112.
6
Detection of Francisella tularensis-specific antibodies in patients with tularemia by a novel competitive enzyme-linked immunosorbent assay.
Clin Vaccine Immunol. 2013 Jan;20(1):9-16. doi: 10.1128/CVI.00516-12. Epub 2012 Oct 31.
7
Development of a novel sandwich immunoassay based on targeting recombinant Francisella outer membrane protein A for the diagnosis of tularemia.
Front Cell Infect Microbiol. 2024 Aug 20;14:1455259. doi: 10.3389/fcimb.2024.1455259. eCollection 2024.
8
[The determination of the antigenic determinant of protective monoclonal antibodies specific to the Francisella tularensis lipopolysaccharide].
Zh Mikrobiol Epidemiol Immunobiol. 1993 Jan-Feb(1):83-8.
9
Immunoglobulin G subclass switching impacts sensitivity of an immunoassay targeting Francisella tularensis lipopolysaccharide.
PLoS One. 2018 Apr 9;13(4):e0195308. doi: 10.1371/journal.pone.0195308. eCollection 2018.
10
Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
Clin Vaccine Immunol. 2009 Mar;16(3):414-22. doi: 10.1128/CVI.00362-08. Epub 2009 Jan 28.
引用本文的文献
1
Virulence of Subspecies Biovar and Phenotypic Change during Serial Passages on Artificial Media.
Microorganisms. 2020 Nov 27;8(12):1881. doi: 10.3390/microorganisms8121881.
2
Complete Genome Sequences of Two Strains of Francisella tularensis subsp. bv. japonica.
Microbiol Resour Announc. 2020 Nov 5;9(45):e01127-20. doi: 10.1128/MRA.01127-20.
3
The binding sites of monoclonal antibodies to the non-reducing end of Francisella tularensis O-antigen accommodate mainly the terminal saccharide.
Immunology. 2013 Nov;140(3):374-89. doi: 10.1111/imm.12150.
4
Detection of Francisella tularensis-specific antibodies in patients with tularemia by a novel competitive enzyme-linked immunosorbent assay.
Clin Vaccine Immunol. 2013 Jan;20(1):9-16. doi: 10.1128/CVI.00516-12. Epub 2012 Oct 31.
5
Characterization of monoclonal antibodies to terminal and internal O-antigen epitopes of Francisella tularensis lipopolysaccharide.
Hybridoma (Larchmt). 2011 Feb;30(1):19-28. doi: 10.1089/hyb.2010.0083.
6
Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
Immunol Lett. 2007 Oct 15;112(2):92-103. doi: 10.1016/j.imlet.2007.07.006. Epub 2007 Aug 8.
本文引用的文献
1
Detection of diverse new Francisella-like bacteria in environmental samples.
Appl Environ Microbiol. 2005 Sep;71(9):5494-500. doi: 10.1128/AEM.71.9.5494-5500.2005.
2
Francisella tularensis enters macrophages via a novel process involving pseudopod loops.
Infect Immun. 2005 Sep;73(9):5892-902. doi: 10.1128/IAI.73.9.5892-5902.2005.
3
A novel screening ELISA and a confirmatory Western blot useful for diagnosis and epidemiological studies of tularemia.
Epidemiol Infect. 2005 Aug;133(4):759-66. doi: 10.1017/s0950268805003742.
4
Tularemia: emergence/re-emergence.
Vet Res. 2005 May-Jun;36(3):455-67. doi: 10.1051/vetres:2005006.
5
Use of monoclonal antibodies for analyses of Coxiella burnetii major antigens.
J Vet Med Sci. 2004 Oct;66(10):1289-91. doi: 10.1292/jvms.66.1289.
6
An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells.
Infect Immun. 2003 Oct;71(10):5940-50. doi: 10.1128/IAI.71.10.5940-5950.2003.
7
Characterization of a novicida-like subspecies of Francisella tularensis isolated in Australia.
J Med Microbiol. 2003 Sep;52(Pt 9):839-842. doi: 10.1099/jmm.0.05245-0.
8
Survival and growth of Francisella tularensis in Acanthamoeba castellanii.
Appl Environ Microbiol. 2003 Jan;69(1):600-6. doi: 10.1128/AEM.69.1.600-606.2003.
9
Tularemia.
Clin Microbiol Rev. 2002 Oct;15(4):631-46. doi: 10.1128/CMR.15.4.631-646.2002.
10
Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain.
Proteomics. 2002 Jul;2(7):857-67. doi: 10.1002/1615-9861(200207)2:7<857::AID-PROT857>3.0.CO;2-L.
Zotero 插件